Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

Sakai Chemical Industry Co / Equity Bottom-Up

<ul><li>1H FY03/26 revenue declined 4.3% YoY to JPY40.4bn, missing the JPY42.0bn forecast, with mixed segment performance.</li><li>Operating profit rose 25.1% YoY to JPY3.3bn, driven by growth in electronic materials and organic chemicals segments.</li><li>Net income surged 67.6% YoY to JPY2.9bn, aided by extraordinary gains from fixed asset sales.</li></ul>

1H FY03/26 revenue declined 4.3% YoY to JPY40.4bn, missing the JPY42.0bn forecast, with mixed segment performance.Operating profit rose 25.1% YoY to JPY3.3bn, driven by growth in electronic materials and organic chemicals segments.Net income surged 67.6% YoY to JPY2.9bn, aided by extraordinary gains from fixed asset sales.

Sakai Chemical Industry Co (4078 JP): 1H FY03/26 flash update

<ul><li>Q1 FY03/26 revenue declined 7.9% YoY to JPY20.1bn, with growth in electronic and organic chemicals segments.</li><li>Operating profit rose 19.3% YoY to JPY1.9bn, driven by electronic materials and organic chemicals growth.</li><li>Net income fell 10.0% YoY to JPY1.3bn, impacted by higher tax expenses and foreign exchange losses.</li></ul>

Q1 FY03/26 revenue declined 7.9% YoY to JPY20.1bn, with growth in electronic and organic chemicals segments.Operating profit rose 19.3% YoY to JPY1.9bn, driven by electronic materials and organic chemicals growth.Net income fell 10.0% YoY to JPY1.3bn, impacted by higher tax expenses and foreign exchange losses.

Sakai Chemical Industry Co (4078 JP): Q1 FY03/26 flash update

<ul><li>FY03/25 revenue reached JPY84.4bn, a 2.8% YoY increase; operating profit rose 107.1% YoY to JPY6.1bn.</li><li>Electronic materials revenue grew 27.5% YoY; titanium dioxide and zinc products turned profitable, aiding overall recovery.</li><li>FY03/26 outlook projects revenue of JPY86.0bn (+1.9% YoY) and operating profit of JPY6.5bn (+6.7% YoY).</li></ul>

FY03/25 revenue reached JPY84.4bn, a 2.8% YoY increase; operating profit rose 107.1% YoY to JPY6.1bn.Electronic materials revenue grew 27.5% YoY; titanium dioxide and zinc products turned profitable, aiding overall recovery.FY03/26 outlook projects revenue of JPY86.0bn (+1.9% YoY) and operating profit of JPY6.5bn (+6.7% YoY).

Sakai Chemical Industry Co (4078 JP): Full-year FY03/25 flash update

<ul><li>Revenue increased 3.7% YoY to JPY21.9bn, with operating profit up 71.2% YoY to JPY1.6bn.</li><li>Chemicals segment, accounting for 90.3% of revenue, saw significant growth in electronic materials (+44.7% YoY).</li><li>Operating profit from electronic materials recovered to JPY340mn, approximately 6.3x YoY, aiding overall profit rise.</li></ul>

Revenue increased 3.7% YoY to JPY21.9bn, with operating profit up 71.2% YoY to JPY1.6bn.Chemicals segment, accounting for 90.3% of revenue, saw significant growth in electronic materials (+44.7% YoY).Operating profit from electronic materials recovered to JPY340mn, approximately 6.3x YoY, aiding overall profit rise.

Sakai Chemical Industry Co (4078 JP): Q1 FY03/25 flash update

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>Price and relative strength trends continue to improve for our international equal-weight Health Care Sector.<br>We recommend adding exposure, and provide charts on numerous actionable stocks across global markets. We also highlight actionable stocks within Materials, beyond metals &amp; mining stocks, that are outperforming. </p>

Price and relative strength trends continue to improve for our international equal-weight Health Care Sector. We recommend adding exposure, and provide charts on numerous actionable stocks across global markets. We also highlight actionable stocks within Materials, beyond metals &amp; mining stocks, that are outperforming. 

Global Strategy: Opportunities in Health Care & Materials Stocks

Japan

SAKAI CHEMICAL INDUSTRY CO., LTD. primarily produces inorganic chemicals.  The Company's main products include titanium oxide, polyvinyl chloride stabilizers, pharmaceuticals, and electronic industry materials.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sakai Chemical Industry Co (4078 JP)